No Data
US Stock MarketDetailed Quotes
ACRX AcelRx Pharmaceuticals
Watchlist
0.6309
-0.0398-5.93% Trading 09/25 15:28 ET
0.6700High0.5600Low349.02KVolume
0.6000Open0.6707Pre Close211.79KTurnover2.77%Turnover RatioLossP/E (TTM)10.31MMarket Cap4.860052wk High0.11P/E (Static)16.34MShares0.550052wk Low0.99P/B7.94MFloat Cap272.8000Historical High--Dividend TTM12.59MShs Float0.5500Historical Low--Div YieldTTM16.40%Amplitude0.6060Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About AcelRx Pharmaceuticals Company
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
DSUVIA1.59M89.67%
DZUVEO183K10.33%
News
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTransCode Therapeutics (NASDAQ:RNAZ) shares increased by 76.2% to $1.17 during Monday's pre-market session. The company's market cap stands at $2.3 million. Biophytis (NASDAQ:BPTS) shares moved
Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday
Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE:STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maintained a Buy rating. Constellation shares fell 0.8% to $
HC Wainwright & Co. Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $5
HC Wainwright & Co. analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $8 to $5.
Comments
$AcelRx Pharmaceuticals(ACRX.US$ bro, can this stock still can keep or sell off ? it keep falling
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--